The effect of Dahuang Shuchong capsules combined with entecavir on hepatic fibrosis and T-cell subsets in patients with hepatitis B liver cirrhosis

YAO Zhong-cai; CAI Ya-jun; SHI Yong-ming; GAO Dong-kai

doi:10.13820/j.cnki.gdyx.20191874

Home>Articles>The effect of Dahuang Shuchong capsules combined with entecavir on hepatic fibrosis and T-cell subsets in patients with hepatitis B liver cirrhosis

DOI: 10.13820/j.cnki.gdyx.20191874

The effect of Dahuang Shuchong capsules combined with entecavir on hepatic fibrosis and T-cell subsets in patients with hepatitis B liver cirrhosis

YAO Zhong-cai

CAI Ya-jun

SHI Yong-ming

GAO Dong-kai

Machine-generated Keywords：

Publication Date：2019-11-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 3141-3146 )

Guangdong Medical Journal

PKUISTIC

ISSN：1001-9448

Year, Vol.(Issue)：2019,40(22)